Literature DB >> 999211

Family studies in dermatitis herpetiformis.

T Reunala, O P Salo, A Tiilikainen, O Selroos, P Kuitunen.   

Abstract

Six families were studied which included 11 members with dermatitis herpetiformis (DH) and three with coeliac disease (CD). Proximal jejunal biopsies performed on 20 relatives revealed villous atrophy in eight. Of these eight, two, both siblings of patients with DH, had a history of juvenile CD. Determinations of histocampatibility (HLA) antigens showed that HLS-B8 occurred in all six families although two patients with DH and one relative with a history of juvenile CD lacked this antigen. In one family the haplotype A1,B8 was associated with DH, villous atrophy, juvenile diabetes and Addison's disease. Skin biopsy failed to reveal IgA in any of the 44 relatives studied for this immunoglobulin. Antireticulin antibody was detected in the sera of seven (17%) relatives.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 999211

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  5 in total

1.  Presence of the autoantibody in healthy relatives of Italian patients with pemphigus vulgaris.

Authors:  A Mohimen; M Narula; V Ruocco; M Pisani; A R Ahmed
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 2.  Dermatitis herpetiformis.

Authors:  R P Hall; T J Lawley; S I Katz
Journal:  Springer Semin Immunopathol       Date:  1981-06

3.  Dermatitis herpetiformis and diabetes mellitus.

Authors:  S Holt; J N Blackwell
Journal:  Postgrad Med J       Date:  1980-01       Impact factor: 2.401

4.  Dermatitis herpetiformis in monozygous twins: discordance for dermatitis herpetiformis and concordance for gluten-sensitive enteropathy.

Authors:  I Kósnai; S Kárpáti; E Török; P Bucsky; E Gyódi
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

Review 5.  Dermatitis Herpetiformis: An Update on Diagnosis and Management.

Authors:  Timo Reunala; Kaisa Hervonen; Teea Salmi
Journal:  Am J Clin Dermatol       Date:  2021-05       Impact factor: 7.403

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.